| Enrolling By Invitation | Clinical Study on the Early Bactericidal Activity of Contezolid Against Mycobacterium Abscessus Disease Monotherapy, Mycobacterium Abscessus Infection | Phase 2 | 2026-01-01 |
| Not Yet Recruiting | Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BLMZ Chinese C Rifampicin Resistant Tuberculosis, Pulmonary Tuberculosis, Tuberculosis | Phase 3 | 2025-12-01 |
| Enrolling By Invitation | Clinical Study on the Early Bactericidal Activity of Sitafloxacin Against Mycobacterium Abscessus Disease Fluoroquinolone, Mycobacterium | Phase 2 | 2025-01-28 |
| Not Yet Recruiting | Phase II Study of Adebrelimab, Chemotherapy, and Apatinib for Advanced Pulmonary Neuroendocrine Tumors Neuroendocrine Tumors | Phase 2 | 2025-01-01 |
| Recruiting | The Safety and Efficacy of BDL(Bedaquiline Plus Delamanid Plus Linezolid) Regimen in Subjects With Pulmonary I Pulmonary Tuberculosis | Phase 4 | 2024-06-01 |
| Enrolling By Invitation | Phase II Clinical Study of Contezolid for the Treatment of Tuberculous Meningitis Tuberculosis, Meningitis | Phase 1 / Phase 2 | 2024-02-01 |
| Enrolling By Invitation | Phase II Clinical Study of Contezolid for the Treatment of Bone and Joint Tuberculosis Tuberculosis, Bone, Joint | Phase 1 / Phase 2 | 2024-01-31 |
| Active Not Recruiting | Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosi Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis | Phase 3 | 2023-12-22 |
| Unknown | Clinical Study of JDB0131 Benzenesulfonate Tablets in Patients With Drug-sensitive Pulmonary Tuberculosis Drug-resistant Tuberculosis | Phase 2 | 2023-10-31 |
| Recruiting | Efficacy Safety BaiDiZiYin ShenQiYiFei Adjunctive Treatments Pulmonary Tuberculosis Adjuvant, Treatment, Tuberculosis | Phase 4 | 2023-05-29 |
| Unknown | Effect of Compound Amino Acid Tablets on Nutritional Status of Patients With Lung Cancer Amino Acid Deficiency, Malnutrition, Lung Cancer | N/A | 2023-04-15 |
| Unknown | Surufatinib in Combination of Durvalumab and EP/EC in the Firstly-line Treatment of ES-SCLC Extensive-stage Small-cell Lung Cancer | Phase 2 | 2022-12-01 |
| Unknown | A Real-World Study of Pyrotinib Maleate in the Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer Wit HER2 Mutant Non-small Cell Lung Cancer | — | 2022-06-30 |
| Unknown | A Study of an Oral Short-course Regimen Including Bedaquiline for the Treatment of Participants With Multidrug Tuberculosis, Multidrug-Resistant | Phase 4 | 2022-05-10 |
| Unknown | A Study of Camrelizumab Combined With Chemotherapy Sequential Camrelizumab Combined With Apatinib Treatment of Non-small Cell Lung Cancer | N/A | 2021-07-07 |
| Unknown | Early Bactericidal Activity Safety Pulmonary Tuberculosis Pyrifazimine (TBI-166) Sensitive Pulmonary Tuberculosis | Phase 2 | 2021-03-01 |
| Unknown | Randomized Controlled Multi-center Short Course Treatment for Rifampicin Resistant Tuberculosis Tuberculosis | N/A | 2020-08-01 |
| Unknown | Safety and Effectiveness of Delamanid-containing Regimen for MDR-TB Patients in China Multidrug Resistant Tuberculosis | Phase 4 | 2020-07-16 |
| Completed | The Effect of 18-month Regimen Containing 6 Anti-tuberculosis Drugs for Patients With MDR-TB Multi-drug Resistant Tuberculosis | Phase 4 | 2019-03-08 |
| Unknown | Optimizing Antituberculosis Therapy in Adults With Tuberculous Meningitis Tuberculous Meningitis | N/A | 2019-03-04 |
| Unknown | The Efficacy and Drug Resistance Molecular Biology of Apatinib Combined With EGFR-TK1 Treated for Advanced Slo Non Small Cell Lung Cancer | Phase 2 | 2018-12-01 |
| Unknown | Mesylate Apatinib Combined With Irinotecan in Treatment of Recurrent Small Cell Lung Cancer Small Cell Lung Cancer | Phase 3 | 2018-09-08 |
| Unknown | Optimizing the Therapeutic Dose of Apatinib Mesylate Tablets in Patients With Lung Cancer by Dose Titration：A NSCLC Stage IV, NSCLC Stage IIIB | N/A | 2018-08-01 |
| Unknown | Study on the Management Model of "Home Treatment" for Tuberculosis Patients Tuberculosis, Pulmonary | N/A | 2018-03-22 |
| Unknown | Shortened Regimens for Drug-susceptible Pulmonary Tuberculosis Tuberculosis, Pulmonary | Phase 4 | 2016-08-01 |
| Unknown | A New Treatment for Primary Smear-positive Pulmonary Tuberculosis With Interleukin-2 Tuberculosis, Pulmonary | Phase 4 | 2016-07-20 |
| Unknown | The Optimal Duration of Preoperative Anti-tuberculosis Treatment of Spinal Tuberculosis Tuberculosis, Spinal | Phase 4 | 2015-04-01 |
| Unknown | Endostar Durative Transfusion Combining With Gemcitabine-Cisplatin to Treat Non-Small Cell Lung Cancer (NSCLC) Non-small Cell Lung Cancer | Phase 2 | 2011-04-01 |
| Completed | Intrathecal Therapy for Adult Tuberculous Meningitis: Impact on Clinical Outcomes Tuberculous Meningitis | — | 2010-01-01 |